Lyell Immunopharma Files 2024 10-K
Ticker: LYEL · Form: 10-K · Filed: Mar 11, 2025 · CIK: 1806952
| Field | Detail |
|---|---|
| Company | Lyell Immunopharma, Inc. (LYEL) |
| Form Type | 10-K |
| Filed Date | Mar 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceutical
TL;DR
Lyell Immunopharma dropped its 2024 10-K. Full financials and biz details inside.
AI Summary
Lyell Immunopharma, Inc. filed its 2024 10-K on March 11, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in South San Francisco, CA, operates in the pharmaceutical preparations sector. Key financial details and operational highlights for the fiscal year 2024 are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Lyell Immunopharma's financial performance, strategic initiatives, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Lyell Immunopharma faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (End date of the reporting period)
- 001-40502 — SEC File Number (Unique identifier for the company's SEC filings)
Key Players & Entities
- Lyell Immunopharma, Inc. (company) — Filer of the 10-K
- 201 HASKINS WAY, SOUTH SAN FRANCISCO, CA 94080 (location) — Company Business and Mail Address
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-11 (date) — Filing Date
FAQ
What is Lyell Immunopharma's primary business sector?
Lyell Immunopharma, Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
When did Lyell Immunopharma file its 2024 10-K?
The 10-K filing for the fiscal year ending December 31, 2024, was filed on March 11, 2025.
Where is Lyell Immunopharma headquartered?
Lyell Immunopharma, Inc. is located at 201 Haskins Way, South San Francisco, CA 94080.
What is the Central Index Key (CIK) for Lyell Immunopharma?
The Central Index Key for Lyell Immunopharma, Inc. is 0001806952.
What is the state of incorporation for Lyell Immunopharma?
Lyell Immunopharma, Inc. is incorporated in Delaware (DE).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 11, 2025 regarding Lyell Immunopharma, Inc. (LYEL).